Mark Rosenthal

Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)

Lucy Gately, Katharine Drummond, Mark Rosenthal, Rosemary Harrup, Anthony Dowling, Andrew Gogos, Zarnie Lwin, Ian Collins, David Campbell, Elizabeth Ahern, Claire Phillips, Hui K Gan, Iwan Bennett, Oliver M Sieber, Peter Gibbs

Journal article  |  2022  |  BMC CANCER

BACKGROUND: Real-world data (RWD) is increasingly being embraced as an invaluable source of information to address clinical and po..

Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial

Macarena de la Fuente, Howard Colman, Mark Rosenthal, Brian A Van Tine, Danijela Levacic, Tobias Walbert, Hui K Gan, Maria Vieito, Mohammed M Milhem, Kathryn Lipford, Sanjeev Forsyth, Sylvie M Guichard, Yelena Mikhailov, Alexander Sedkov, Julie Brevard, Patrick F Kelly, Hesham Mohamed, Varun Monga

Journal article  |  2022  |  NEURO-ONCOLOGY

BACKGROUND: Olutasidenib (FT-2102) is a highly potent, orally bioavailable, brain-penetrant and selective inhibitor of mutant isoc..

Physical activity and glioma: a case-control study with follow-up for survival

Zohreh Basiri, Yi Yang, Fiona J Bruinsma, Anna K Nowak, Kerrie L McDonald, Katharine J Drummond, Mark A Rosenthal, Eng-Siew Koh, Rosemary Harrup, Elizabeth Hovey, David Joseph, Geza Benke, Robyn Leonard, Robert J MacInnis, Roger L Milne, Graham G Giles, Claire M Vajdic, Brigid M Lynch

Journal article  |  2022  |  CANCER CAUSES & CONTROL

PURPOSE: High-grade disease accounts for ~ 70% of all glioma, and has a high mortality rate. Few modifiable exposures are known to..

Consensus core clinical data elements for meningiomas (v2021.1)

Farshad Nassiri, Justin Z Wang, Karolyn Au, Jill Barnholtz-Sloan, Michael D Jenkinson, Kate Drummond, Yueren Zhou, James M Snyder, Priscilla Brastianos, Thomas Santarius, Suganth Suppiah, Laila Poisson, Francesco Gaillard, Mark Rosenthal, Timothy Kaufmann, Derek Tsang, Kenneth Aldape, Gelareh Zadeh

Journal article  |  2021  |  NEURO-ONCOLOGY

BACKGROUND: With increasing molecular analyses of meningiomas, there is a need to harmonize language used to capture clinical data..

Palliative Care Clinical Trials: Building Capability and Capacity

Jennifer Philip, Brian Le, Leeanne Pasanen, Evelien Rosens, Aaron Wong, Ruwani Mendis, Mark Boughey, Maria Coperchini, Juli Moran, Jenny Hynson, Jenny Weil, Mark Rosenthal

Journal article  |  2021  |  JOURNAL OF PALLIATIVE MEDICINE

Clinical trials are a key component of expanding the evidence base in palliative care. A key strategic objective of the Victorian ..

INNV-08. LOW AND INTERMEDIATE GRADE GLIOMA UMBRELLA STUDY OF MOLECULAR GUIDED THERAPIES (LUMOS) STUDY

Benjamin Kong, Hao-Wen Sim, Benhur Amanuel, Bryan Day, Michael Buckland, Roel Verhaak, Sonia Yip, Terrance Johns, Zarnie Lwin, Mark Rosenthal, Anna K Nowak, Elizabeth H Barnes, Andrew M Scott, Jonathon Parkinson, Rosalind Jeffree, Richard De Abreu Lourenco, Peter Lau, James Whittle, Elizabeth Hovey, Lawrence Cher, et al.

Conference Proceedings  |  2021  |  Neuro-Oncology

Abstract BACKGROUND Grade 2 and 3 (G2/3) gliomas are the second largest group ..

Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial

KM Field, EH Barnes, HW Sim, AK Nowak, J Simes, MA Rosenthal, H Wheeler, EJ Hovey, LM Cher

Journal article  |  2021  |  JOURNAL OF CLINICAL NEUROSCIENCE

Assessment of neurocognitive function (NCF) is important in brain tumor clinical trials, however there are varying methodologies a..

LOW AND INTERMEDIATE GRADE GLIOMA UMBRELLA STUDY OF MOLECULAR GUIDED THERAPIES (LUMOS) STUDY

Benjamin Kong, Hao-Wen Sim, Benhur Amanuel, Bryan Day, Michael Buckland, Roel Verhaak, Sonia Yip, Terrance Johns, Zarnie Lwin, Mark Rosenthal, Anna K Nowak, Elizabeth H Barnes, Andrew M Scott, Jonathon Parkinson, Rosalind Jeffree, Richard De Abreu Lourenco, Peter Lau, James Whittle, Elizabeth Hovey, Lawrence Cher, et al.

Conference Proceedings  |  2021  |  NEURO-ONCOLOGY

Systems-Level Change to Alleviate Barriers to Cancer Clinical Trial Access for Adolescents and Young Adults in Australia

Justine A Ellis, Vajiranee S Malalasekera, Christie Allan, Peter F Choong, Jordan R Hansford, Ryan Hehir, Natasha Morello, Sally O'Callaghan, Lisa Orme, Nitya Phillipson, Mark A Rosenthal, Susan Sawyer, Robyn Strong, Leanne Super, Angela Watt, Chris Williams, Anne Woollett, Alexandra Robertson, Jeremy Lewin

Journal article  |  2021  |  JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY

Purpose: International data demonstrate association between clinical trial participation and reduced cancer mortality. Adolescents..

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study

Hao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, Elizabeth H Barnes, Mark Rosenthal, Matthew C Foote, Eng-Siew Koh, Michael Back, Helen Wheeler, Erik P Sulman, Michael E Buckland, Lauren Fisher, Robyn Leonard, Merryn Hall, David M Ashley, Sonia Yip, John Simes, Mustafa Khasraw

Journal article  |  2021  |  NEURO-ONCOLOGY

BACKGROUND: Temozolomide offers minimal benefit in patients with glioblastoma with unmethylated O6-methylguanine-DNA methyltransfe..